Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression
Status:
Terminated
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Stimulant drugs such as dextroamphetamine-amphetamine and methylphenidate may help
improve memory, attention, and thinking problems caused by central nervous system (CNS)
treatment for cancer, and may help decrease depression.
PURPOSE: This randomized phase II trial is studying dextroamphetamine-amphetamine to see how
well it works compared to methylphenidate in treating depression and problems with memory,
attention, and thinking in children who have undergone CNS treatment for cancer. This trial
will also study how often depression is seen and if these medications might help.